HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptors.

AbstractBACKGROUND:
Retinoid Receptors are involved in development and cell homeostasis. Alterations of their expressions have been observed in lung cancer. However, retinoid chemoprevention trials in populations at risk to develop such tumors have failed. Therefore, the pertinence of new clinical trials using second generation retinoid requires prior better understanding of retinoid signalling. This is our aim when validating extensively research tools, focused on Retinoic Acid Receptor beta, whose major role in lung cancer is documented.
METHODS:
Biocomputing was used to assess the genomic organization of RAR beta. Its putative RAR-beta1' promoter features were investigated experimentally. Specific measures realized, with qRT-PCR Syber Green assays and a triplex of Taqman probes, were extensively validated to establish Retinoid Receptors mRNAs reference values for in vivo normal human bronchial cells, lung tumors and cell lines. Finally, a pan-RAR-beta antibody was generated and extensively validated by western-blot and immunoprecipitation.
RESULTS:
No promoter-like activity was found for RAR-beta1'. RAR-beta2 mRNAs increase signs the normal differentiation of the human bronchial epithelium while a decrease is observed in most lung cancer cell lines. Accordingly, it is also, along with RXR beta, down-regulated in lung tumors. When using nuclear extracts of BEAS-2B and normal lung cells, only the RAR-beta2 long protein isoform was recognized by our antibody.
CONCLUSION:
Rigorous samples processing and extensive biocomputing, were the key factors for this study. mRNA reference values and validated tools can now be used to advance researches on retinoid signalling in the lung.
AuthorsStéphane Poulain, Stéphanie Lacomme, Shyue-Fang Battaglia-Hsu, Stanislas du Manoir, Lydia Brochin, Jean-Michel Vignaud, Nadine Martinet
JournalBMC cancer (BMC Cancer) Vol. 9 Pg. 423 (Dec 04 2009) ISSN: 1471-2407 [Electronic] England
PMID19961602 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Protein Isoforms
  • RNA, Messenger
  • Receptors, Retinoic Acid
  • retinoic acid receptor beta
Topics
  • Base Sequence
  • Blotting, Western
  • Gene Expression Profiling (methods, standards)
  • Humans
  • Immunoprecipitation
  • Lung (metabolism)
  • Lung Neoplasms (genetics, metabolism)
  • Molecular Sequence Data
  • Promoter Regions, Genetic
  • Protein Isoforms (metabolism)
  • RNA, Messenger (analysis, genetics)
  • Receptors, Retinoic Acid (genetics, metabolism)
  • Reference Values
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: